Sprodiamide

N/A

Report date: 2023/02/11 20:38:29
NME

Base Information

Drug NameSprodiamide
Drug Alias NameDyDTPA-BMAWIN-59080S-043
ClassificationSmall moleculesDiagnostic agent (In vivo)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCerebrovascular Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGe Healthcare
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGe Healthcare
Active IndicationsN/A
Inactive IndicationsCerebrovascular Disorders

Other Information

ATC CodeN/A
Related LinksKEGG